Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$101,203,860
+$23,173,092 QoQ
Shares Held
6,998,884
+27.7% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. FOLD ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101,203,860 | 6,998,884 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $78,030,768 | 5,479,689 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $25,205,516 | 3,198,670 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $24,595,230 | 4,292,362 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $19,813,570 | 2,428,134 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,986,110 | 2,121,668 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $45,019,731 | 4,215,331 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $49,527,847 | 4,992,727 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $114,323,105 | 9,704,848 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $189,122,854 | 13,327,897 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $130,704,090 | 10,748,692 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $164,043,743 | 13,060,808 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $182,995,075 | 16,500,909 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $217,818,508 | 17,839,354 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $179,395,870 | 17,183,513 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $196,687,843 | 18,313,580 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $163,086,199 | 17,221,352 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $157,546,903 | 13,640,425 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $111,624,111 | 11,688,389 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $112,400,295 | 11,659,782 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $98,469,659 | 9,966,565 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $293,955,487 | 12,730,857 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $156,926,642 | 11,113,785 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $125,848,329 | 8,345,380 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $114,344,537 | 12,374,950 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||